Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
about
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancersDual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusionTuning cell migration: contractility as an integrator of intracellular signals from multiple cuesThe molecular mechanisms of hemodialysis vascular access failureSplicing Regulation: A Molecular Device to Enhance Cancer Cell AdaptationPosttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologySplicing Regulators and Their Roles in Cancer Biology and TherapyConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responseSplice isoforms as therapeutic targets for colorectal cancerPhosphorylation-mediated regulation of alternative splicing in cancerVascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySpecific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative SplicingMolecular Imaging of Angiogenesis in Cardiac RegenerationAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedRegulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesisMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Overexpression of VEGF165b in podocytes reduces glomerular permeability.Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts.Recombinant human VEGF165b inhibits experimental choroidal neovascularizationPosterior reversible encephalopathy syndrome in a postpartum hemorrhagic woman without hypertension: A case report.Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMIVascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina.Tumor and reproductive traits are linked by RNA metabolism genes in the mouse ovary: a transcriptome-phenotype association analysisAlternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.Therapeutic potential of manipulating VEGF splice isoforms in oncologyThe anti-angiogenic isoforms of VEGF in health and disease.VEGF-A165b is cytoprotective and antiangiogenic in the retinaMolecular diversity of VEGF-A as a regulator of its biological activity.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling.Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesityDo anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleBorrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoformsRole of the endothelium in inflammatory bowel diseases.Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses.Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.
P2860
Q24302434-A715610A-3AB7-4A9C-B32A-EDC064951680Q24339549-E84B3EC4-DD4A-44F6-AD16-5B0331D2282CQ26742035-B6432F54-5A0D-4327-8AE5-1E1A44495710Q26775058-EFCEF6E2-3C40-4A82-ACB4-601F6FC7E9EDQ26798148-CCCC2692-F62E-4A4E-9359-BBC9D9AD5082Q26798154-9B1824FC-C60D-49E7-B5CD-A7F5C7BF2BE8Q26798158-B5101C4B-0D77-43C5-B89A-6578AC366520Q26824298-65BC4CEA-4057-497F-82DF-4F6E75435DA3Q27006500-AAD2D3D3-3DAF-4986-83D0-9DF9964C7E46Q27009883-E61E89A0-F4FE-48B5-9B31-EB7ACAE83B2CQ27342809-453432FA-AA3A-49E9-9098-A75892F247CFQ27666758-E21A682B-6A8E-4365-89C4-943DFFE7DD7EQ28073273-436B98CB-A3AD-4620-874B-0C1F8D808841Q28297381-9B32B4B1-33CD-444C-9F13-1CA6B9C222DEQ28513991-89970BDE-EF25-41AA-937B-CED1950244C1Q30278005-2502B186-5F87-43D9-A680-EBB83366DC0EQ30497786-CFADFD82-2738-42B9-9646-557A5D1DF399Q30891401-09161977-86DE-4C4E-BE82-8DC46CCFC7AFQ33410394-16558FC5-FEBB-475D-A7CA-166F6FD7CCBFQ33541827-D8EC7132-932D-4058-89BA-91D27FA8DC45Q33606272-63A39088-9C98-4C5A-B6C0-8300527DBA9DQ33705257-67AD48B3-D09A-43E2-93EA-BF77C0BD7A65Q33739109-F62B2318-AA0D-467C-9EFA-2B77FC7F2428Q33742338-871EE68C-6F47-49F5-A0C1-A50A0A2F94DAQ33787240-2095A7E9-DCAB-429A-BF01-88E5420CA78AQ33800261-20F4D0CE-EABC-457A-9169-A64A4E0C40E7Q33888458-58EF3F16-0BC2-4B4B-A88C-4E6DB062BAC7Q33901839-E027CBF7-AFDB-4911-A7D7-D0FF2D5D5284Q34022623-AF182A69-8C3B-48D0-AC1C-0DFB77B55161Q34089123-1CE89B32-3A3B-42EC-97F2-3D8F9C553A9AQ34109028-314263EC-1716-4105-B4CD-DFCFD023BCE7Q34112722-750E6AAB-E5AA-4562-BC18-856EE5A722FAQ34244804-F58DFE33-4EE8-4E7E-976A-AC0BA9CA4AC5Q34261539-41B8AC94-01EE-4301-ADB9-54409FF24D4AQ34347768-CAD84F64-5264-41BA-945B-594EDF2C4A51Q34579746-153A16E2-7985-4B14-AF4A-2703DCDC077DQ34621550-F376C710-049E-405B-ABA5-CE38DD00FEB6Q34656053-F4CB684A-60D6-4188-A7AD-048B484F7397Q34675574-7965D919-91F0-4E8A-8831-A64BABD384D4Q34712017-638FDC96-2E3E-4352-A4F1-9747F66F0B1E
P2860
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Expression of pro- and anti-an ...... y splicing and growth factors.
@en
Expression of pro- and anti-an ...... y splicing and growth factors.
@nl
type
label
Expression of pro- and anti-an ...... y splicing and growth factors.
@en
Expression of pro- and anti-an ...... y splicing and growth factors.
@nl
prefLabel
Expression of pro- and anti-an ...... y splicing and growth factors.
@en
Expression of pro- and anti-an ...... y splicing and growth factors.
@nl
P2093
P2860
P356
P1476
Expression of pro- and anti-an ...... y splicing and growth factors.
@en
P2093
Amanda J Churchill
Dawid G Nowak
Elianna Mohamed Amin
Jeanette Woolard
Michael R Ladomery
Moin A Saleem
Olga Konopatskaya
Steven J Harper
P2860
P304
P356
10.1242/JCS.016410
P407
P577
2008-10-01T00:00:00Z